ProShares Ultra Nasdaq Biotechnology (BIB) Short Interest Ratio & Short Volume → Will this AI Micro-Cap be Bigger than NVIDIA? (From Behind the Markets) (Ad) Free BIB Stock Alerts $57.84 -0.81 (-1.38%) (As of 06/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends ProShares Ultra Nasdaq Biotechnology Short Interest DataCurrent Short Interest5,600 sharesPrevious Short Interest12,100 sharesChange Vs. Previous Month-53.72%Dollar Volume Sold Short$314,104.00Short Interest Ratio0.2 Days to CoverLast Record DateMay 31, 2024Outstanding Shares1,630,000 sharesPercentage of Shares Shorted0.34%Today's Trading Volume7,578 sharesAverage Trading Volume33,016 sharesToday's Volume Vs. Average23% Short Selling ProShares Ultra Nasdaq Biotechnology ? Sign up to receive the latest short interest report for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBIB Short Interest Over TimeBIB Days to Cover Over TimeBIB Percentage of Float Shorted Over Time Ad Behind the MarketsWill this AI Micro-Cap be Bigger than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout AI stock. But right now... There's only ONE AI stock you should be watching.Get the full story here >>> ProShares Ultra Nasdaq Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20245,600 shares $314,104.00 -53.7%N/A0.2 $56.09 5/15/202412,100 shares $696,113.00 -25.3%N/A0.4 $57.53 4/30/202416,200 shares $817,290.00 -56.3%N/A0.5 $50.45 4/15/202437,100 shares $1.86 million +201.6%N/A0.9 $50.24 3/31/202412,300 shares $707,742.00 -77.9%N/A0.3 $57.54 3/15/202455,700 shares $3.12 million +98.2%N/A1.3 $56.04 2/29/202428,100 shares $1.62 million +53.6%N/A0.7 $57.80 2/15/202418,300 shares $1.06 million +2.2%N/A0.6 $58.07 1/31/202417,900 shares $1.02 million No ChangeN/A0.5 $57.11 BIB Short Interest - Frequently Asked Questions What is ProShares Ultra Nasdaq Biotechnology's current short interest? Short interest is the volume of ProShares Ultra Nasdaq Biotechnology shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 5,600 shares of BIB short. Learn More on ProShares Ultra Nasdaq Biotechnology's current short interest. Is ProShares Ultra Nasdaq Biotechnology's short interest increasing or decreasing? ProShares Ultra Nasdaq Biotechnology saw a drop in short interest in May. As of May 31st, there was short interest totaling 5,600 shares, a drop of 53.7% from the previous total of 12,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ProShares Ultra Nasdaq Biotechnology's short interest compare to its competitors? Here is how the short interest of companies compare to ProShares Ultra Nasdaq Biotechnology: Invesco Nasdaq Biotechnology ETF (0.51%), Principal Healthcare Innovators ETF (0.01%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (9.59%), Invesco S&P SmallCap Health Care ETF (0.02%), VanEck Biotech ETF (0.07%), VanEck Pharmaceutical ETF (23.91%), and iShares Biotechnology ETF (16.13%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short ProShares Ultra Nasdaq Biotechnology stock? Short selling BIB is an investing strategy that aims to generate trading profit from ProShares Ultra Nasdaq Biotechnology as its price is falling. BIB shares are trading down $0.81 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProShares Ultra Nasdaq Biotechnology? A short squeeze for ProShares Ultra Nasdaq Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIB, which in turn drives the price of the stock up even further. How often is ProShares Ultra Nasdaq Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIB, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies: IBBQ Short Squeeze BTEC Short Squeeze FTXH Short Squeeze JDOC Short Squeeze BIS Short Squeeze PSCH Short Squeeze BBH Short Squeeze PPH Short Squeeze IBB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIB) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.